Genome-wide gene expression profiling to predict resistance to anthracyclines in breast cancer patients

Validated biomarkers predictive of response/resistance to anthracyclines in breast cancer are currently lacking. The neoadjuvant Trial of Principle (TOP) study, in which patients with estrogen receptor (ER)–negative tumors were treated with anthracycline (epirubicin) monotherapy, was specifically de...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Genom Data
Main Authors: Haibe-Kains, B., Desmedt, C., Di Leo, A., Azambuja, E., Larsimont, D., Selleslags, J., Delaloge, S., Duhem, C., Kains, J.P., Carly, B., Maerevoet, M., Vindevoghel, A., Rouas, G., Lallemand, F., Durbecq, V., Cardoso, F., Salgado, R., Rovere, R., Bontempi, G., Michiels, S., Buyse, M., Nogaret, J.M., Qi, Y., Symmans, F., Pusztai, L., D'Hondt, V., Piccart-Gebhart, M., Sotiriou, C.
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2013
Assuntos:
Data in Brief
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4608867/
https://ncbi.nlm.nih.gov/pubmed/26484051
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.gdata.2013.09.001
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados